Pan Du

Nanjing Vazyme Biotech Co., Ltd.

Nanjing

China

SCHOLARLY PAPERS

1

DOWNLOADS

97

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (1)

1.

Safety and Immunogenicity of Heterologous Boosting With a Protein-Subunit-Based COVID-19 Vaccine (ZF2001) in Healthy Adults Previously Received One Dose of Convidecia: A Randomised, Observer-Blinded, Placebo-Controlled Trial

Number of pages: 36 Posted: 10 Jan 2022
Chinese Center for Disease Control and Prevention (China CDC) - NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Anhui Zhifei Longcom Biopharmaceutical Co. LTD., Chinese Center for Disease Control and Prevention (China CDC) - Guanyun County Center for Disease Control and Prevention, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Chinese Academy of Sciences (CAS) - CAS Key Laboratory of Pathogenic Microbiology and Immunology, Nanjing Vazyme Biotech Co., Ltd., Chinese Center for Disease Control and Prevention (China CDC) - Guanyun County Center for Disease Control and Prevention, Southeast University, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Nanjing Vazyme Biotech Co., Ltd., Anhui Zhifei Longcom Biopharmaceutical Co. LTD., Chinese Academy of Sciences (CAS) - CAS Key Laboratory of Pathogenic Microbiology and Immunology, Anhui Zhifei Longcom Biopharmaceutical Co. LTD., Nanjing Medical University, Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology and Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology
Downloads 97 (525,737)

Abstract:

Loading...

SARS-CoV-2, heterologous immunisation, recombinant adenovirus type-5-vectored COVID-19 vaccine, protein-subunit-based COVID-19 vaccine, clinical trial